GXO Logistics (GXO) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
13 Nov, 2025Executive summary
Achieved record Q3 2025 revenue of $3.4 billion, up 8% year-over-year, with organic growth in every region and 4% organic revenue growth.
Net income rose to $60 million, a 71% increase year-over-year, and diluted EPS increased to $0.51 from $0.28.
Adjusted EBITDA grew 13% to $251 million, with margins expanding 100 bps sequentially and 30 bps year-over-year.
New business wins totaled $280 million in Q3, up 24% year-over-year, with a $2.3 billion sales pipeline and $700 million in incremental 2026 revenue secured.
Wincanton integration is progressing, targeting $60 million in cost synergies by end of 2026 and supporting growth in Europe.
Financial highlights
Q3 2025 revenue: $3.4 billion (+8% YoY, +4% organic); adjusted EBITDA: $251 million (+13% YoY); net income: $60 million; adjusted net income: $91 million.
Diluted EPS: $0.51 (up from $0.28 YoY); adjusted diluted EPS: $0.79.
Free cash flow: $187 million; operating cash flow: $232 million; cash and cash equivalents: $339 million.
Net debt at $2.4 billion; total debt at $2.7 billion; net leverage ratio at 2.7x.
Operating ROIC at 48.6%–49% and adjusted EBITDA margin at 7.4% (up from 7.1% YoY).
Outlook and guidance
Reaffirmed 2025 guidance: organic revenue growth of 3.5%–6.5%, adjusted EBITDA of $865–$885 million, adjusted diluted EPS of $2.43–$2.63, and free cash flow conversion of 25%–35%.
Margin expansion expected in 2026 as Wincanton synergies materialize.
Plans to update long-term guidance at Investor Day in 2026.
Liquidity is sufficient for at least the next 12 months, with $969 million in borrowing capacity.
Latest events from GXO Logistics
- Record revenue and new business wins drive strong 2026 outlook and margin expansion.GXO
Q4 202511 Feb 2026 - Q2 revenue up 19% to $2.85B, but net income down 41% amid acquisition and litigation costs.GXO
Q2 20242 Feb 2026 - Q3 revenue up 28% to $3.2B, strong pipeline, but net income down on higher costs.GXO
Q3 202416 Jan 2026 - Record 2024 results and strong 2025 outlook with margin expansion and robust pipeline.GXO
Q4 202415 Dec 2025 - 2024 saw record results, board refreshment, and a focus on ESG and pay-for-performance.GXO
Proxy Filing1 Dec 2025 - Q2 2025 revenue up 16%, guidance raised, Wincanton deal approved, CEO transition underway.GXO
Q2 202523 Nov 2025 - Q1 revenue up 21% to $3B, net loss $95M, guidance reaffirmed, and NHS contract boosts outlook.GXO
Q1 202519 Nov 2025